WallStreetZenWallStreetZen

NASDAQ: DNTH
Dianthus Therapeutics Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Dianthus Therapeutics revenue was $6.52M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q1 2025) ending on Mar 31, 2025 was $1.2M, down 12.3% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, DNTH annual revenue was $6.2M, with 120.6% growth year-over-year.

DNTH past revenue growth

How has DNTH's revenue growth performed historically?

Company
102.36%
Industry
1,361.15%
Market
34.96%
DNTH's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
DNTH's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
DNTH's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

DNTH revenue history

Current Revenue
$6.5M
Current Earnings
-$100.7M
Current Profit Margin
-1,544%

Be the first to know when DNTH announces revenue.

DNTH Revenue History By Year

DNTH Yearly RevenueDNTH RevenueDNTH ChangeDNTH Revenue Growth
2024-12-31$6.24M$3.41M+120.63%
2023-12-31$2.83M-$3.59M-55.96%
2022-12-31$6.42MN/AN/A
2021-12-31$0.00N/AN/A
2020-12-31$0.00N/AN/A
2019-12-31$0.00N/AN/A
2018-12-31$0.00N/AN/A
2017-12-31$0.00N/AN/A
2016-12-31$0.00N/AN/A

1 of 1

Dianthus Therapeutics Revenue FAQ

What was DNTH's revenue last quarter?

On Invalid Date, Dianthus Therapeutics (NASDAQ: DNTH) reported Q1 2025 revenue of $1.16 million up 33.07% year over year. In the same quarter last year, Dianthus Therapeutics's revenue was $874.00 thousand.

What was Dianthus Therapeutics's revenue in 2024?

Dianthus Therapeutics's annual revenue for the twelve months ending Dec 31, 2024 was $6.24 million, a 120.63% increase year over year.

How much does Dianthus Therapeutics make in a day?

Based on Dianthus Therapeutics annual revenue for the past five years, DNTH makes an average of $8,481.10 per day.

What was Dianthus Therapeutics's annual revenue growth in the past year?

As of Q2 2025, Dianthus Therapeutics's revenue has grown 102.36% year over year. This is 1,258.79 percentage points lower than the US Biotechnology industry revenue growth rate of 1,361.15%. Dianthus Therapeutics's revenue in the past year totaled $6.52 million.

How much does Dianthus Therapeutics make in a year?

Dianthus Therapeutics's revenue by year for the past five years is:
  • Dianthus Therapeutics's revenue for the twelve months ending Dec 31, 2024 was $6.24 million, a 120.63% increase year over year.
  • Dianthus Therapeutics's annual revenue for Dec 31, 2023 was $2.83 million, a 55.96% decrease from 2022.
  • Dianthus Therapeutics's annual revenue for 2022 was $6.42 million, a Infinity% increase from 2021.
  • Dianthus Therapeutics's annual revenue for 2021 was $0.00, a N/A decrease from 2020.
  • Dianthus Therapeutics's annual revenue for 2020 was $0.00, a N/A decrease from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.